Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $344000.0.

  • Pyxis Oncology's Change in Account Payables rose 15714.29% to $344000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 13421.73% up from last year.
  • As of Q3 2025, Pyxis Oncology's Change in Account Payables stood at $344000.0, which was up 15714.29% from $6.6 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Change in Account Payables peaked at $6.6 million during Q2 2025, and registered a low of -$2.0 million during Q1 2025.